Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform

Study limitation reported by the research below: “Study design is a secondary analysis; causal inference is limited by residual confounding (e.g., unrecorded bone-protective therapy use).”